These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35067240)
1. SARS-CoV-2-associated Guillain-Barré syndrome: a descriptive and comparative analysis. Cárdenas-Rodríguez MA; Meléndez-Flores JD; Villarreal-Garza E; Flores-Alfaro F; Pérez-Arzola AA; De la Fuente-Martínez JA; González-Dávila SE; Chávez-Luévanos B; Estrada-Bellmann I Can J Neurol Sci; 2023 Jan; 50(1):135-137. PubMed ID: 35067240 [No Abstract] [Full Text] [Related]
2. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome. Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006 [No Abstract] [Full Text] [Related]
3. Guillain-Barré syndrome after SARS-CoV-2 infection. Kilinc D; van de Pasch S; Doets AY; Jacobs BC; van Vliet J; Garssen MPJ Eur J Neurol; 2020 Sep; 27(9):1757-1758. PubMed ID: 32533876 [No Abstract] [Full Text] [Related]
7. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection]. Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738 [TBL] [Abstract][Full Text] [Related]
8. Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature. Al Jaberi M; Shihadat R; Masri A Childs Nerv Syst; 2022 Oct; 38(10):2011-2016. PubMed ID: 35461356 [TBL] [Abstract][Full Text] [Related]
9. Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome. Scorza FA; Finsterer J Travel Med Infect Dis; 2021; 44():102201. PubMed ID: 34774758 [No Abstract] [Full Text] [Related]
11. Variant Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature. Donaldson L; Margolin E Can J Neurol Sci; 2023 Jan; 50(1):138-140. PubMed ID: 35532270 [No Abstract] [Full Text] [Related]
12. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome. Ling L; Bagshaw SM; Villeneuve PM CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163 [No Abstract] [Full Text] [Related]
14. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit. Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941 [TBL] [Abstract][Full Text] [Related]
15. Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients. Doneddu PE; De Sanctis P; Viganò L; Selmi C; Gentile F; Nobile-Orazio E Eur J Neurol; 2021 Jan; 28(1):e9. PubMed ID: 32978868 [No Abstract] [Full Text] [Related]
16. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2. Leung C Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555 [TBL] [Abstract][Full Text] [Related]